News
-
-
-
-
-
-
PRESS RELEASE
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) will conduct an investor webcast on April 1, 2024, at 8:30 a.m. EST to review fourth-quarter financials and corporate updates. Company plans to file its Earnings Report on Form 10-K for year ended December 31, 2023 -
-
-
PRESS RELEASE
GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market
Jaguar Health, Inc. announces exclusive license agreement with GEN for crofelemer products in key territories, including payment of double-digit royalties. Agreement covers FDA-approved indications and potential follow-on uses -